Jiangsu Hansoh Pharmaceutical Group Competitors and Similar CompaniesClear all
Jiangsu Hansoh Pharmaceutical Group's competitors and similar companies include Yabao Pharmaceutical, Takeda, CureVac and PLIVA.
 Yabao Pharmaceutical Yabao Pharmaceutical Group ( 亚宝药业) is a company that specializes in the production, logistics, and distribution of medicines. |  Takeda Takeda Pharmaceutical (武田薬品工業株式会社) is a biopharmaceutical company engaged in the research, development, production, and commercialization of pharmaceutical products. |  PLIVA PLIVA HRVATSKA is a pharmaceutical company focused on the development of generic and niche products. | |||
Founding Date | Founding Date 1995 | Founding Date 1978 | Founding Date 1781 | Founding Date 2000 | Founding Date 1921 |
Type | Type Public | Type Public | Type Public | Type Public | Type Subsidiary |
Tags | |||||
Locations | Locations Lianyungang Shi, CN HQ | Locations Yuncheng Shi, CN HQ Beijing, CN Yuncheng, CN Yuncheng Shi, CN | Locations Tübingen, DE HQ Ottignies Louvain La Neuve, BE Wiesbaden, DE Amsterdam, NL Basel, CH Boston, US | Locations Zagreb, HR HQ Sarajevo, BA Skopje, MK Belgrade, RS | |
Employees | Employees 8,989 | Employees 3,611 | Employees 47,4554% decrease | Employees 82517% decrease | Employees 1,685 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 613.8 m | Valuation ($) 43.7 b | Valuation ($) 648.3 m | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) ¥15b (FY, 2025) | Revenue (est.) ¥2.2b (FY, 2025) | Revenue (est.) ¥4.5t (FY, 2026) | Revenue (est.) €535.2m (FY, 2024) | Revenue (est.) N/A |
Cost of goods | Cost of goods ¥1.1b (FY, 2025) | Cost of goods ¥1.1b (FY, 2025) | Cost of goods ¥850.5b (FY, 2026) | Cost of goods €9.7m (FY, 2024) | Cost of goods N/A |
Gross profit | Gross profit ¥14b (FY, 2025) | Gross profit ¥1.1b (FY, 2025) | Gross profit ¥3.7t (FY, 2026) | Gross profit €534.4m (FY, 2024) | Gross profit N/A |
Net income | Net income ¥5.6b (FY, 2025) | Net income ¥299.9m (FY, 2025) | Net income ¥192b (FY, 2026) | Net income €162.2m (FY, 2024) | Net income N/A |
Operating ⚠ | |||||
Phase I Trials Products | Phase I Trials Products N/A | Phase I Trials Products N/A | Phase I Trials Products 2 (May, 2025) | Phase I Trials Products 3 (May, 2020) | Phase I Trials Products N/A |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 57.8m | Total funding raised $ 1.1b | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Yabao Pharmaceutical
HQ
Yuncheng Shi, CN
Employees
3,611
Yabao Pharmaceutical Group ( 亚宝药业) is a company that specializes in the production, logistics, and distribution of medicines.
View companyTakeda
HQ
Tokyo, JP
Employees
47,455↓ 4% decrease
Takeda Pharmaceutical (武田薬品工業株式会社) is a biopharmaceutical company engaged in the research, development, production, and commercialization of pharmaceutical products.
View company
CureVac
HQ
Tübingen, DE
Employees
825↓ 17% decrease
CureVac is a biotechnology company offering messenger RNA (mRNA) technology.
View companyPLIVA
HQ
Zagreb, HR
PLIVA HRVATSKA is a pharmaceutical company focused on the development of generic and niche products.
View company